Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3601 AL 3615

Animal Models of Freezing of Gait

Coletta S, Papa SM.

Eur J Neurosci. 2026 May;63(9):e70537. doi: 10.1111/ejn.70537.

Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease

Lorkiewicz SA, Abdelnour C, Bolen M, Smith AM, Shahid-Besanti M, Hemachandra D, Müller-Oehring EM, Siddiqui N, Montoliu-Gaya L, Arslan B, Ashton NJ, Wilson EN, Tian L, Andreasson KI, Mormino EC, Henderson VW, Zetterberg H, Poston KL.

medRxiv [Preprint]. 2026 Mar 27:2026.03.26.26349399. doi: 10.64898/2026.03.26.26349399.

Progress in modelling ATP13A2-linked neurodegeneration

Balbo B, Kinet R, Civiero L, Dehay B.

NPJ Parkinsons Dis. 2026 Apr 4;12(1):132. doi: 10.1038/s41531-026-01331-w.

Metric validation for detection of delayed and directed coupling

Dembny K, Farooqi H, Herman AB, Netoff TI, Darrow DP.

J Neural Eng. 2026 May 14;23(3):036012. doi: 10.1088/1741-2552/ae5fd7.

The lifespan continuum of brain disorders: investigating links between neurodevelopmental and neurodegenerative disease-chicken or egg?

Sian-Hulsmann J, Knudsen LV, Sheldrick-Michel AJ, Riederer P, Michel TM.

J Neural Transm (Vienna). 2026 Jan 6. doi: 10.1007/s00702-025-03078-9. Online ahead of print.

Towards a Biologically Defined Diagnosis: Incorporating Pathophysiological Measures Into Parkinson's Disease Clinical Criteria

McNamara A, Carr LM, Baetu I, Jenkinson M, Collins-Praino L.

Parkinsons Dis. 2026 Feb 25;2026:2703114. doi: 10.1155/padi/2703114. eCollection 2026.

Insulin Resistance Across Cerebrovascular and Related Disorders: Mechanisms, Measurement, Genetics, and Clinical Implications

Chen K, Nong Y, Liu Y, Ye Z.

Neuropsychiatr Dis Treat. 2026 Apr 30;22:575306. doi: 10.2147/NDT.S575306. eCollection 2026.

The footprint of ethnopharmacology in drug discovery (ISE-APSS2024)

Lall N, Leonti M, Schultz F, McGaw L, Mandiwana V.

J Ethnopharmacol. 2026 May 29:121941. doi: 10.1016/j.jep.2026.121941. Online ahead of print.

Neurosenescence, inflammaging and neuroinflammation in neurodegenerative disorders

Kempuraj D, Ramesh Babu PR, Jayakumar N, Belur MG, Cohan CH, Sharma A, Sanchez-Guerrero E, Anderson T, Kong D, Chinnappan B, Pena C, Klimas NG, Theoharides TC.

Front Aging. 2026 Mar 9;7:1756670. doi: 10.3389/fragi.2026.1756670. eCollection 2026.

Targeting the NLRP3 inflammasome with antibody-based therapeutics for chronic neurodegenerative diseases

Sandhu JK, Tanha J, Arbabi-Ghahroudi M.

Expert Opin Ther Targets. 2026 Apr;30(4):309-328. doi: 10.1080/14728222.2026.2671675. Epub 2026 May 21.

Emerging Roles, Mechanisms, and Therapeutic Potential of Thyroid Hormones in Neurodegenerative Diseases: A Review

Li X, Li Z, Sun M, Du Y, Bai H, Chen X, Wang J.

Brain Sci. 2026 Feb 14;16(2):229. doi: 10.3390/brainsci16020229.

Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives

Kwaśniewska K, Fic W, Polak-Szczybyło E.

Nutrients. 2026 Mar 20;18(6):995. doi: 10.3390/nu18060995.

Neurobiology of exercise in Parkinson's disease

Rodriguez TN, Smeyne RJ, Smeyne M.

J Parkinsons Dis. 2026 May 20:1877718X261452869. doi: 10.1177/1877718X261452869. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias